EUVIMEDEUVIMED entdecken
Open Access

Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity

Bhavyata Pandya Shesh, Becky Slagle-Webb, Ganesh Shenoy, Vladimir Khristov, Brad E Zacharia, James R Connor

Journal of Cancer Research and Clinical Oncology · 2023

DOI: 10.1007/s00432-023-04864-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2023. Verfasst von Bhavyata Pandya Shesh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Iron acquisition is key to maintaining cell survival and function. Cancer cells in general are considered to have an insatiable iron need. Iron delivery via the transferrin/transferrin receptor pathway has been the canonical iron uptake mechanism. Recently, however, our laboratory and others have explored the ability of ferritin, particularly the H-subunit, to deliver iron to a variety of cell types. Here, we investigate whether Glioblastoma (GBM) initiating cells (GICs), a small population of stem-like cells, are known for their iron addiction and invasive nature acquire exogenous ferritin, as a source of iron. We further assess the functional impact of ferritin uptake on the invasion capacity of the GICs. METHODS: To establish that H-ferritin can bind to human GBM, tissue-binding assays were performed on samples collected at the time of surgery. To interrogate the functional consequences of H-ferritin uptake, we utilized two patient-derived GIC lines. We further describe H-ferritin's impact on GIC invasion capacity using a 3D invasion assay. RESULTS: H-ferritin bound to human GBM tissue at the amount of binding was influenced by sex. GIC lines showed uptake of H-ferritin protein via transferrin receptor. FTH1 uptake correlated with a significant decrease in the invasion capacity of the cells. H-ferritin uptake was associated with a significant decrease in the invasion-related protein Rap1A. CONCLUSION: These findings indicate that extracellular H-ferritin participates in iron acquisition to GBMs and patient-derived GICs. The functional significance of the increased iron delivery by H-ferritin is a decreased invasion capacity of GICs potentially via reduction of Rap1A protein levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansApoferritinsIronFerritinsReceptors, TransferrinStem Cells

Stichwörter der Autor:innen

FerritinGlioblastomaGlioblastoma stem cellsInvasionIron

Substanzen

ApoferritinsIronFerritinsReceptors, Transferrin

Autor:innen und Institutionen

  • Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA.
  • Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA. jconnor@pennstatehealth.psu.edu.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Pandya Shesh, B., Slagle-Webb, B., Shenoy, G., Khristov, V., Zacharia, B. E., & Connor, J. R. (2023). Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04864-2

Vancouver

Pandya Shesh B, Slagle-Webb B, Shenoy G, Khristov V, Zacharia BE, Connor JR. Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity. Journal of Cancer Research and Clinical Oncology. 2023. doi:10.1007/s00432-023-04864-2

BibTeX
@article{PandyaShesh2023,
  author = {Pandya Shesh, Bhavyata and Slagle-Webb, Becky and Shenoy, Ganesh and Khristov, Vladimir and Zacharia, Brad E and Connor, James R},
  title = {Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2023},
  doi = {10.1007/s00432-023-04864-2}
}
Kostenlos starten →